Atlas Trials

Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients

Clinical trial NCT02910219 · COMPLETED

Trial details

NCT number
NCT02910219
Sponsor
Sandra Swain
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2017-01-31
Primary completion
2020-11-23
Enrollment
53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.